Ameriprise Financial Inc Coherus Bio Sciences, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 61,449 shares of CHRS stock, worth $99,547. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,449

Previous 61,449 -0.0%

Holding current value

$99,547

Previous $106,000 40.57%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.58 - $2.51 $97,089 - $154,236	61,449 New	61,449 $106,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $756,962 - $1.83 Million	-476,077 Reduced 97.21%	13,666 $45,000
Q3 2023 Nov 14, 2023	SELL	$3.74 - $5.45 $959,018 - $1.4 Million	-256,422 Reduced 34.37%	489,743 $1.83 Million
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $2.36 Million - $5.16 Million	-621,655 Reduced 45.45%	746,165 $3.19 Million
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $2.7 Million - $4.83 Million	-458,876 Reduced 25.12%	1,367,820 $9.36 Million
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $3,328 - $5,890	585 Added 0.03%	1,826,696 $14.5 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $845,285 - $1.64 Million	-117,892 Reduced 6.06%	1,826,111 $17.5 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $509,064 - $1.15 Million	86,871 Added 4.68%	1,944,003 $14.1 Million
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $1.85 Million - $2.78 Million	169,307 Added 10.03%	1,857,132 $24 Million
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $4.7 Million - $5.64 Million	296,981 Added 21.35%	1,687,825 $26.9 Million
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $1,648 - $2,312	130 Added 0.01%	1,390,844 $22.4 Million
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $1.82 Million - $2.17 Million	140,705 Added 11.26%	1,390,714 $19.2 Million
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $9.55 Million - $14.2 Million	-661,998 Reduced 34.62%	1,250,009 $18.3 Million
Q4 2020 Feb 12, 2021	SELL	$16.56 - $18.94 $7.51 Million - $8.59 Million	-453,721 Reduced 19.18%	1,912,007 $33.2 Million
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $25.5 Million - $29.1 Million	-1,464,385 Reduced 38.23%	2,365,728 $43.4 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $5.65 Million - $7.51 Million	391,779 Added 11.39%	3,830,113 $68.4 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $21.9 Million - $42.4 Million	1,880,196 Added 120.67%	3,438,334 $55.8 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $14.2 Million - $18.6 Million	871,346 Added 126.87%	1,558,138 $28.1 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $8.12 Million - $11.6 Million	498,282 Added 264.33%	686,792 $13.9 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $4.73 Million - $7.97 Million	-360,813 Reduced 65.68%	188,510 $4.17 Million
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $261,497 - $483,677	31,205 Added 6.02%	549,323 $7.49 Million
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $2.88 Million - $5.42 Million	333,108 Added 180.05%	518,118 $4.69 Million
Q3 2018 Nov 14, 2018	SELL	$14.45 - $20.25 $525,113 - $735,885	-36,340 Reduced 16.42%	185,010 $3.05 Million
Q2 2018 Aug 14, 2018	SELL	$10.25 - $17.45 $1.96 Million - $3.33 Million	-191,105 Reduced 46.33%	221,350 $3.1 Million
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $847,392 - $1.28 Million	-93,120 Reduced 18.42%	412,455 $4.56 Million
Q4 2017 Feb 12, 2018	BUY	$8.35 - $14.4 $1.51 Million - $2.6 Million	180,885 Added 55.71%	505,575 $4.45 Million
Q3 2017 Nov 07, 2017	BUY	$11.1 - $14.5 $3.6 Million - $4.71 Million	324,690	324,690 $4.34 Million

Others Institutions Holding CHRS

# of Institutions

134

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $126M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Coherus Bio Sciences, Inc. Transaction History